Published on in Vol 10 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/51090, first published .
German Version of the mHealth App Usability Questionnaire in a Cohort of Patients With Cancer: Translation and Validation Study

German Version of the mHealth App Usability Questionnaire in a Cohort of Patients With Cancer: Translation and Validation Study

German Version of the mHealth App Usability Questionnaire in a Cohort of Patients With Cancer: Translation and Validation Study

Journals

  1. Šafran V, Lin S, Nateqi J, Martin A, Smrke U, Ariöz U, Plohl N, Rojc M, Bēma D, Chávez M, Horvat M, Mlakar I. Multilingual Framework for Risk Assessment and Symptom Tracking (MRAST). Sensors 2024;24(4):1101 View
  2. Deshmukh A, Chalmeta R. Validation of system usability scale as a usability metric to evaluate voice user interfaces. PeerJ Computer Science 2024;10:e1918 View
  3. Anders C, Moorthy P, Svensson L, Müller J, Heinze O, Knaup P, Wallwiener M, Deutsch T, Le T, Weinert L. Usability and User Experience of an mHealth App for Therapy Support of Patients With Breast Cancer: Mixed Methods Study Using Eye Tracking. JMIR Human Factors 2024;11:e50926 View
  4. Zimmermann J, Morf H, Scharf F, Knitza J, Moeller H, Muehlensiepen F, Nathrath M, Orlemann T, Voelker T, Deckers M. German Version of the Telehealth Usability Questionnaire and Derived Short Questionnaires for Usability and Perceived Usefulness in Health Care Assessment in Telehealth and Digital Therapeutics: Instrument Validation Study. JMIR Human Factors 2024;11:e57771 View
  5. Oudbier S, Smets E, Nieuwkerk P, Neal D, Nurmohamed A, Meij H, Dusseljee-Peute L. Measuring is knowing - Evaluating patients’ experienced usability of and satisfaction with digital health solutions for self-management: validation of the GEMS questionnaire (Preprint). JMIR Medical Informatics 2024 View
  6. Ashkani N, Erfannia L, Rezaee R, Savareh B, Bashiri A. Developing and validating a content quality evaluation tool for cancer mobile applications. BMC Cancer 2024;24(1) View